The pan‐deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2744|54|8|585-597

ISSN： 0899-1987

Source： Molecular Carcinogenesis, Vol.54, Iss.8, 2015-08, pp. : 585-597

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The PI3K/AKT signaling pathway: Associations of miRNAs with dysregulated gene expression in colorectal cancer

By  

Molecular Carcinogenesis, Vol. 57, Iss. 2, 2018-02 ,pp. : 243-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aurora kinase A mediates c‐Myc's oncogenic effects in hepatocellular carcinoma

By  

Molecular Carcinogenesis, Vol. 54, Iss. 11, 2015-11 ,pp. : 1467-1479

John Wiley & Sons Inc

Access to resources Recommend Favorite

Loss expression of micro ribonucleic acid (miRNA)‐200c induces adverse post‐surgical prognosis of advanced stage non‐small cell lung carcinoma and its potential relationship with ETAR messenger RNA

By  

Thoracic Cancer, Vol. 6, Iss. 4, 2015-07 ,pp. : 421-426

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of a functional RAD52 genetic variant locating in a miRNA binding site with risk of HBV‐related hepatocellular carcinoma

By  

Molecular Carcinogenesis, Vol. 54, Iss. 9, 2015-09 ,pp. : 853-858

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR‐200c‐3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment

By  

Molecular Carcinogenesis, Vol. 57, Iss. 2, 2018-02 ,pp. : 295-302

John Wiley & Sons Inc

Access to resources Recommend Favorite